Market Insights Health Hospitals Inpatient Care

Gastroenterology - Netherlands

Netherlands

The Netherlands is expected to see a significant increase in revenue within the Gastroenterology market.
By 2024, the projected revenue is estimated to reach €1.54bn.
This growth is expected to continue at an annual growth rate of 2.35%, resulting in a market volume of €1.73bn by 2029.
When compared globally, United States is expected to generate the highest revenue within this market, with €56,090.00m in 2024.
The Netherlands is experiencing a growing trend in the adoption of advanced endoscopic procedures in the field of gastroenterology.

Key regions: France, China, Japan, United States, Europe

Marché

Région

Comparaison de régions

Monnaie

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.